D

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Dec 23, 2019
Document Date
Dec 23, 2019
Filing Group
Other
Company
KemPharm
Issuer
KEMPHARM, INC